D. VanderWeele

发表

Svf1 inhibits reactive oxygen species generation and promotes survival under conditions of oxidative stress in Saccharomyces cerevisiae

C. Rudin, J. Brace, D. VanderWeele, 2005, Yeast.

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

C. Rudin, L. Schumaker, E. Zuhowski, 2003, Cancer research.

Cisplatin Resistance Inhibition of Glutathione Synthesis Reverses Bcl-2-mediated Updated Version Cited Articles Citing Articles E-mail Alerts Inhibition of Glutathione Synthesis Reverses Bcl-2-mediated Cisplatin Resistance We Tested This Hypothesis Using Mcf-7 Breast Cancer Cells Transfected with th

C. Rudin, L. Schumaker, E. Zuhowski, 2022 .

Precision management of localized prostate cancer

B. Turkbey, A. Sowalsky, D. VanderWeele, 2016, Expert review of precision medicine and drug development.

Accelerating precision medicine in metastatic prostate cancer

A. Chinnaiyan, N. Schultz, E. V. Van Allen, 2020, Nature Cancer.

Nascent prostate cancer heterogeneity drives evolution and resistance to intense hormonal therapy

P. Choyke, M. Merino, S. Harmon, 2020, medRxiv.

Trimodality Treatment for Muscle-Invasive Bladder Cancer: An Institutional Experience

J. Meeks, A. Morgans, M. Hussain, 2021, Advances in radiation oncology.

Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.

J. Lack, A. Sowalsky, G. Paner, 2017, European urology focus.

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.

P. Choyke, M. Merino, S. Harmon, 2019, Urologic oncology.

Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate.

Sanjay G. Patel, S. Eggener, A. Weiner, 2015, Urology.